For generations, obsessive-compulsive disorder and chronic tic disorders have been managed at the surface — their inner biological architecture remaining largely hidden. A study published in Nature Neuroscience has now identified 36 genes that substantially raise the risk of these conditions, revealing shared brain pathways and offering pharmaceutical researchers more than 30 concrete targets for intervention. The discovery marks a quiet but profound shift: from treating what people suffer to understanding why their brains are suffering.